Eribulin and Rhophylac

• Generic Name: eribulin
• Dosage Forms: n.a.
• Other Brand Names: Halaven

Eribulin is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Eribulin is used to treat breast cancer that has spread to other parts of the body.

Eribulin is also used to treat liposarcoma, a rare type of cancer that develops in fatty tissue anywhere in the body. Eribulin is used for liposarcoma that cannot be treated with surgery, or has spread throughout the body.

Eribulin is usually given after at least 2 other combinations of chemotherapy medications have been tried without successful treatment of symptoms.

Eribulin may also be used for purposes not listed in this medication guide.

• Generic Name: rho (d) immune globulin
• Dosage Forms: injection
• Other Brand Names: HyperRHO S/D Full Dose, HyperRHO S/D Mini Dose, MicRhoGAM, MicRhoGAM Ultra-Filtered Plus, RhoGAM, RhoGAM Ultra-Filtered Plus, Rhophylac, WinRho SDF, Gamulin Rh, Mini-Gamulin Rh, HypRho-D Mini-Dose, BayRho-D, BayRHo-D Full Dose, BayRHo-D Mini-Dose, Anti-D Immunoglobulin, D-Gam Anti-D, Partobulin SDF, Liberim D

Rhophylac contains RHo (D) immune globulin. RHo (D) immune globulin is a sterilized solution made from human blood. Rh is a substance that most people have in their blood (Rh positive) but some people don't (Rh negative). A person who is Rh negative can be exposed to Rh positive blood through a mismatched blood transfusion or during pregnancy when the baby has the opposite blood type. When this exposure happens, the Rh negative blood will respond by making antibodies that will try to destroy the Rh positive blood cells. This can cause medical problems such as anemia (low red blood cells), kidney failure, or shock.

Rhophylac is used to prevent an immune response to Rh positive blood in people with an Rh negative blood type. Rhophylac may also be used in the treatment of immune thrombocytopenic purpura (ITP).

Rhophylac may also be used for purposes not listed in this medication guide.